Gk Pharmacomm Limited in Kirkby Lonsdale, LA6 2FT

Description

Data updated on: 01-11-2023

Gk Pharmacomm Limited can be gotten hold of in Abbots Brow, Swine Market in Kirkby Lonsdale. The firm postal code is LA6 2FT. Gk Pharmacomm has been operating on the market since it was established in 2007. The firm registered no. is 06158799. It has operated under three names. The company's very first name, Gk Pharmacomm, was changed on 2008-11-27 to Gk Pharmacomm & Events. The current name is in use since 2010, is Gk Pharmacomm Limited. The enterprise's Standard Industrial Classification Code is 86900, that means Other human health activities. 2023-03-31 is the last time account status updates were reported.

Gill H. and Katy P. are registered as the enterprise's directors and have been doing everything they can to help the company since 2007. What is more, the director's efforts are backed by a secretary - Stephen P., who was chosen by this company in August 2020.

Previous company's names
Gk Pharmacomm Limited 2010-05-14
Gk Pharmacomm & Events Limited 2008-11-27
Gk Pharmacomm Limited 2007-03-14

Financial data based on annual reports

Profit & Loss
Date of Accounts	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
Currency
Net Worth	920 776	926 594	900 166

Balance Sheet
Cash Bank On Hand			235 218	192 306	378 984	977 110	1 084 083	1 511 874	1 323 409	3 612 652
Current Assets	987 442	1 024 594	960 739	1 197 848	1 412 964	2 141 801	2 442 559	3 317 341	3 952 725	3 713 851
Debtors	87 530	158 715	117 620	275 260	271 633	361 051	307 352	321 879	311 361	99 699
Net Assets Liabilities			929 561	1 048 836	1 181 746	1 782 329	2 158 033	3 007 520	3 593 205	3 502 333
Other Debtors			77	11 233	8 427	122 471	105 482	65 343		22 179
Property Plant Equipment			21 662	10 539	12 539	9 990	8 361	8 626	12 820	17 807
Cash Bank In Hand	694 375	257 395	235 218
Intangible Fixed Assets	105 000	70 000	35 000
Tangible Fixed Assets	22 810	21 275	21 662

Capital & Reserves
Called Up Share Capital	1 000	1 000	1 000
Profit Loss Account Reserve	919 776	925 594	899 166
Shareholder Funds	920 776	926 594	900 166

Other Financial Data
Accrued Liabilities Deferred Income			5 135	5 220	72 282
Accumulated Amortisation Impairment Intangible Assets			315 000	350 000	350 000	350 000	350 000	350 000	350 000
Accumulated Depreciation Impairment Property Plant Equipment			21 036	10 641	13 329	15 878	17 877	15 125	12 699	18 395
Additions Other Than Through Business Combinations Property Plant Equipment				6 124	4 689		370	6 721	7 436	10 683
Amounts Recoverable On Contracts			12 450	105 400	105 276	93 755	55 875	41 385	111 912	27 786
Average Number Employees During Period							3	3	3	3
Balances Amounts Owed By Related Parties										20 000
Corporation Tax Payable			67 327	74 563	85 075
Creditors			115 314	135 657	216 757	340 203	284 322	252 919	292 740	148 365
Current Asset Investments	205 537	608 484	607 901	730 282	762 347	803 640	1 051 124	1 483 588	2 317 955	1 500
Fixed Assets	127 810	91 275	56 662	10 539
Increase From Amortisation Charge For Year Intangible Assets				35 000
Increase From Depreciation Charge For Year Property Plant Equipment				2 289	2 688	2 549	1 999	4 107	3 242	5 696
Intangible Assets			35 000
Intangible Assets Gross Cost			350 000	350 000	350 000	350 000	350 000	350 000	350 000
Net Current Assets Liabilities	795 200	837 076	845 425	1 062 191	1 196 207	1 801 598	2 158 237	3 064 422	3 659 985	3 565 486
Number Shares Issued Fully Paid					1	1
Other Creditors			87	86	68	38 029	40 845	33 620	70 133	52 938
Other Disposals Decrease In Depreciation Impairment Property Plant Equipment				12 685				6 859	5 668
Other Disposals Property Plant Equipment				27 643				9 208	5 668
Other Investments Other Than Loans						803 640	1 051 124	1 483 588	2 317 955	1 500
Other Taxation Social Security Payable					85 075	190 424	171 776	194 155	193 588	92 810
Par Value Share		1	1		1	1
Prepayments Accrued Income			3 035	3 156	3 247	4 285	6 346	11 171	5 768	6 270
Property Plant Equipment Gross Cost			42 698	21 179	25 868	25 868	26 238	23 751	25 519	36 202
Provisions For Liabilities Balance Sheet Subtotal			8 816	23 894	27 000	29 259	8 565	65 528	79 600	80 960
Taxation Including Deferred Taxation Balance Sheet Subtotal			8 816	23 894
Total Assets Less Current Liabilities	923 010	928 351	902 087	1 072 730	1 208 746	1 811 588	2 166 598	3 073 048	3 672 805	3 583 293
Trade Creditors Trade Payables			42 765	55 788	59 332	111 750	71 701	25 144	29 019	2 617
Trade Debtors Trade Receivables			102 059	155 471	154 683	140 540	139 649	203 980	193 681	43 464
Creditors Due Within One Year	192 242	187 518	115 314
Intangible Fixed Assets Aggregate Amortisation Impairment	245 000	280 000	315 000
Intangible Fixed Assets Amortisation Charged In Period		35 000	35 000
Intangible Fixed Assets Cost Or Valuation	350 000	350 000	350 000
Number Shares Allotted		1	1
Provisions For Liabilities Charges	2 234	1 757	1 921
Share Capital Allotted Called Up Paid	1	1	1
Tangible Fixed Assets Additions		1 064	2 829
Tangible Fixed Assets Cost Or Valuation	38 805	39 869	42 698
Tangible Fixed Assets Depreciation	15 995	18 594	21 036
Tangible Fixed Assets Depreciation Charged In Period		2 599	2 442

Company staff

Stephen P.

Role: Secretary

Appointed: 10 August 2020

Latest update: 2 February 2024

Gill H.

Role: Director

Appointed: 14 March 2007

Latest update: 2 February 2024

Katy P.

Role: Director

Appointed: 14 March 2007

Latest update: 2 February 2024

People with significant control

Executives who have control over the firm are as follows: Katy P. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Gill H. owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Katy P.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

right to manage directors

1/2 or less of shares

Gill H.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

right to manage directors

1/2 or less of shares

Accounts Documents

Account next due date	31 December 2024
Account last made up date	31 March 2023
Confirmation statement next due date	28 March 2024
Confirmation statement last made up date	14 March 2023

Annual Accounts 2 June 2015
Start Date For Period Covered By Report	2014-04-01
End Date For Period Covered By Report	2015-03-31
Date Approval Accounts	2 June 2015
Annual Accounts 16 July 2016
Start Date For Period Covered By Report	2015-04-01
End Date For Period Covered By Report	2016-03-31
Date Approval Accounts	16 July 2016
Annual Accounts
Start Date For Period Covered By Report	2016-04-01
End Date For Period Covered By Report	2017-03-31
Annual Accounts
Start Date For Period Covered By Report	2017-04-01
End Date For Period Covered By Report	2018-03-31
Annual Accounts
Start Date For Period Covered By Report	2018-04-01
End Date For Period Covered By Report	2019-03-31
Annual Accounts
Start Date For Period Covered By Report	2019-04-01
End Date For Period Covered By Report	2020-03-31
Annual Accounts
Start Date For Period Covered By Report	2020-04-01
End Date For Period Covered By Report	2021-03-31
Annual Accounts
Start Date For Period Covered By Report	2021-04-01
End Date For Period Covered By Report	2022-03-31
Annual Accounts
Start Date For Period Covered By Report	2022-04-01
End Date For Period Covered By Report	2023-03-31

Gk Pharmacomm Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Stephen P.

Gill H.

Katy P.

Gill H.

People with significant control

Katy P.

Gill H.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies